Articles related to ATRIAL FIBRILLATION (AFIB)

In reverse order of popularity: 10. PECARN Pediatric Head Injury/Trauma Algorithm9. GAD-7 (General Anxiety Disorder-7)8. Ideal Body Weight and Adjusted Body Weight7. Steroid Conversion Calculator6. Calcium Correction for Hypoalbuminemia5. MELD Score (Model For End-Stage Liver Disease) (12 and older)4. Mean Arterial Pressure (MAP)3. CHA₂DS₂-VASc Score for Atrial Fibrillation Stroke Risk2. PHQ-9 (Patient Health Questionnaire-9)1. Creatinine Clearance (Cockcroft-Gault Equation)

A UK study reports that a history of irregular menstrual cycle was associated with higher risk for afib in women. A finding from the Vitamin D and Omega 3 Trial (VITAL) Rhythm Study reveals that when controlled for height and body size, women are at higher risk than men for afib, suggesting that biological sex and body size account for much of the protective effect of female sex. And as separately reported, early rhythm control is associated with lower risk for CV events as compared to usual care.

Exploring the Korean National Health Insurance claims database revealed that rhythm control via ablation or drugs, initiated within 1 year of diagnosis of AF, was associated with lower risk for cardiovascular events. This held true for both low risk and higher risk patients. The study analyzed data on more than 35,000 patients with a median age of 70.

What is the best strategy for preventing stroke in patients with non-valvular AF: anticoagulants or left atrial appendage occlusion (LAAO)? The answer depends on the individual patient’s combination of stroke and bleeding risks. In this study, combined risks favored LAAO for higher bleeding risk, but that benefit became less certain at higher stroke risks.

More than 15 professional societies now recommend the use of icosapent ethyl to treat ASCVD, but clinical questions about the use of omega-3 fatty acids remain. Drs. Leslie Cho and Erin Michos discuss the role of DHA and EPA and whether all omega-3 fatty acids are the same. But what about EPA plasma levels, incidence of atrial fibrillation, and differences between the STRENGTH and REDUCE-IT trials? Tune in to get these answers and more in this 13-minute, 0.25-CME credit hours video podcast.